Alnylam Pharmaceuticals , Inc.

Company Description

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company developing therapeutics based on ribonucleic acid interference (RNAi). RNAi is a naturally occurrin


$25 mil. - $50 Revenue

300 Third StreetCambridgeMassachusetts02142United States

view map

(617) 551-8200(617) 551-8101Fax

Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.

More Company Info

Mergers & Acquisitions

Alnylam Europe AG

Stock Market


SIC Codes




Recently updated profiles at this company
(137 contacts available)
Lubomir Nechev
Vice President, Process Sciences
Rachel Meyers
Vice President, Research and RLD
Kevin FitzGerald
Senior Director Research
Renee Leck
Senior Analyst
  • View Contact Info >>
  • Contact people at this company
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.